Analgesia Flashcards
1
Q
Opioids - Mechanism of Action
A
- Bind and stimulate μ receptors. With increasing doses, starts to stimulate κ and δ receptors
- Pre-synaptic - close calcium channels, decreasing intracellular calcium in presynaptic terminals of afferent fibres, inhibiting NT release
- Post-synaptic - opens potassium channels, increasing intracellular calcium causing hyper-polarisation (inhibitory post-synaptic potential)
2
Q
Opioids - Central Effects
A
- Analgesia
- Sedation, but no amnesia
- Cough reflex suppression (e.g. codeine and dextromethorphan)
- Euphoria
- Respiratory depression (important to note in asthmatics), increases carbon dioxide, causing vasodilation. Pethidine does so less than morphine (so used in labour)
- Raised intracranial pressure (secondary to vasodilation)
- Miosis/ pinpoint pupils (pre-existing miosis must be diagnosed before drug administration, important consideration with suspected head injury, does not occur with pethidine)
- Nausea and vomiting (counteracted by cyclizine/ H1 receptor antagonist)
- Truncal muscle rigidity at supraspinal level - particularly fentanyl (counteracted by a neuromuscularblocker)
3
Q
Opioids - Peripheral Effects
A
- Constipation (worsened with atropine and metoclopramide)
- CVS - peripheral arterial and venous dilation and decreased TPR, resulting in hypotension (mediated by histamine release)
- Histamine release - pruritis/ rash, bronchospasm (therefore opiates CI in poorly controlled asthmatics or COPD patients)
- Genitourinal tract - increased sphincter tone, and urine retention
- Neuroendocrine - increased ADH, prolactin and somatotrophin release
- Biliary tract - biliary colic (use pethidine rather as it has an antimuscarinic effect)
- Uterus - morphine can prolong labour and decrease contraction rate (use pethidine as it has an antimuscarinic effect)
4
Q
Opioids - Contraindications
A
- Head injury
- Shock
- Liver dysfunction
- Heroin addicts
- Asthma
- COPD
5
Q
Pethidine
A
- Antimuscarinic properties (counteracts miosis and causes tachycardia)
- Drug of choice in asthmatics
- Metabolised to norpethidine, which is neurotoxic (resulting in seizures)
- Naloxone reversal is less effective
- Half lives - pethidine 2.5-4 hours; norpethidine 8-21 hours
- Serotonin syndrome with monoamine oxidase inhibitors
6
Q
Fentanyl
A
- Rapid onset of action
- Short duration of action (half life 1-1.6 hours)
- Effective for continuous infusion (especially the analogue remifentanil)
- Potent analgesic that does not depress the CVS, therefore used as post-surgical analgaesia in cardiac patients
- Duration of reparatory depression is less than that of morphine
- Less histamine release, therefore less side effects
7
Q
Tramadol
A
- Partial μ receptor antagonist and serotonin & noradrenaline reuptake inhibitor
- Causes nausea and vomiting
- High oral bioavailability
- At analgesic doses, there is no respiratory depression or CVS adverse effects
- May cause seizures (especially if there is head trauma)
- CNS depressent effects
- No histamine release
- Drug interactions with serotnin and noradrenaline drugs
8
Q
NSAIDS - Contraindications
A
Absolute
- GIT bleeding or ulceraton on history
- Hypersensitivity
- Severe liver dysfunction
- Cardiac failure
- Dehydration, hypotension, hypovolemia
- Hyperkalemia
- Renal impairment
- Aspirin-induced asthma
Relative
- Bleeding or coagulation disorders
- Surgery with high risk of hemorrhage
- Surgery where absence of bleeding is important
- Drugs (ACE-I, anticoagulants, methotrexate, cyclosporin, gentamycin)
- Pregnancy and lactation
- Age > 65
9
Q
Ketamine
A
- MOA: antagonist at NMDA glutamate receptors
- No respiratory depression
- Psychiatric effects
10
Q
Morphine Dose
A
- Infusion: 0.07-0.5mg/kg/hour
- Intermittent dose: 0.01-0.5mg/kg 1-2 hourly (10-30mg usually…)
11
Q
Fentanyl Dosage
A
100-200mcg IV